New drug cocktail aims to wipe out breast cancer before surgery
NCT ID NCT04877821
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed phase 2 trial tested a combination of sintilimab (an immunotherapy), anlotinib (a drug that blocks blood vessel growth), and standard chemotherapy in 29 people with early-stage triple-negative breast cancer. The treatment was given before surgery to shrink or eliminate the tumor. The main goal was to see how many patients had no cancer left at the time of surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sintilimab (immunotherapy), anlotinib (anti-angiogenesis drug), nab-paclitaxel, and carboplatin (chemotherapy)
- What this could lead to
- If successful, this combination could become a new pre-surgery treatment option for early triple-negative breast cancer, potentially improving the chance of eliminating all cancer before surgery.
- What could go wrong
- This is a small, early-phase trial with only 29 participants, so results may not apply to all patients. The combination also carries risks of side effects from immunotherapy, anti-angiogenesis drugs, and chemotherapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NeoSACT
Guangzhou, Guangdong, 510080, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a High-Fiber diet shield the gut during breast cancer therapy?
- Can mapping tumor DNA unlock personalized breast cancer care?
- Can a Two-Pronged antibody boost Chemo's power against a tough breast cancer?
- Can a new drug rally the immune system against Hard-to-Treat cancers?
- Could an oral chemo pill improve breast cancer treatment?
- Can a new nucleotide analogue boost cancer treatment?